Abstract
Virtual screening is increasingly being used in drug discovery programs with a growing number of successful applications. Experimental methodologies developed to speed up the drug discovery processes include high throughput screening and combinatorial chemistry. The complementarities between computational and experimental screenings have been recognized and reviewed in the literature. Computational methods have also been used in the combinatorial chemistry field, in particular in library design. However, the integration of computational and combinatorial chemistry screenings has been attempted only recently. Combinatorial libraries (experimental or virtual) represent a notable source of chemically related compounds. Advances in combinatorial chemistry and deconvolution strategies, have enabled the rapid exploration of novel and dense regions in the chemical space. The present review is focused on the integration of virtual and experimental screening of combinatorial libraries. Applications of virtual screening to discover novel anticancer agents and our ongoing efforts towards the integration of virtual screening and combinatorial chemistry are also discussed.
Keywords: AKT, cancer, DNA methyltransferase, docking, kinase, libraries from libraries, molecular similarity, combinatorial chemistry, drug discovery, high throughput screening, QSAR
Combinatorial Chemistry & High Throughput Screening
Title: Integrating Virtual Screening and Combinatorial Chemistry for Accelerated Drug Discovery
Volume: 14 Issue: 6
Author(s): Fabian Lopez-Vallejo, Thomas Caulfield, Karina Martinez-Mayorga, Marc A. Giulianotti, Adel Nefzi, Richard A. Houghten and Jose L. Medina-Franco
Affiliation:
Keywords: AKT, cancer, DNA methyltransferase, docking, kinase, libraries from libraries, molecular similarity, combinatorial chemistry, drug discovery, high throughput screening, QSAR
Abstract: Virtual screening is increasingly being used in drug discovery programs with a growing number of successful applications. Experimental methodologies developed to speed up the drug discovery processes include high throughput screening and combinatorial chemistry. The complementarities between computational and experimental screenings have been recognized and reviewed in the literature. Computational methods have also been used in the combinatorial chemistry field, in particular in library design. However, the integration of computational and combinatorial chemistry screenings has been attempted only recently. Combinatorial libraries (experimental or virtual) represent a notable source of chemically related compounds. Advances in combinatorial chemistry and deconvolution strategies, have enabled the rapid exploration of novel and dense regions in the chemical space. The present review is focused on the integration of virtual and experimental screening of combinatorial libraries. Applications of virtual screening to discover novel anticancer agents and our ongoing efforts towards the integration of virtual screening and combinatorial chemistry are also discussed.
Export Options
About this article
Cite this article as:
Lopez-Vallejo Fabian, Caulfield Thomas, Martinez-Mayorga Karina, A. Giulianotti Marc, Nefzi Adel, A. Houghten Richard and L. Medina-Franco Jose, Integrating Virtual Screening and Combinatorial Chemistry for Accelerated Drug Discovery, Combinatorial Chemistry & High Throughput Screening 2011; 14(6) . https://dx.doi.org/10.2174/138620711795767866
DOI https://dx.doi.org/10.2174/138620711795767866 |
Print ISSN 1386-2073 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5402 |

- Author Guidelines
- Editorial Policies
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Allegations from Whistleblowers
- Publishing Ethics and Rectitude
- Increase Visibility Of Your Article
- Archiving Policies
- Reviewer Guidelines
- Guest Editor Guidelines
- Board Recruitment Workflow
- Short Guide for New Editors
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Announcements
- Forthcoming Thematic Issues
Related Articles
-
Role of Drug Metabolism in the Cytotoxicity and Clinical Efficacy of Anthracyclines
Current Drug Metabolism 6-hydroxydopamine Lesion of the Mesolimbic Dopamine System Alters Morphine-Induced Conditioned Reinforcement
Current Psychopharmacology Techniques to Investigate Neuronal Mitochondrial Function and its Pharmacological Modulation
Current Drug Targets Approaches and Resources for Prediction of the Effects of Non-Synonymous Single Nucleotide Polymorphism on Protein Function and Interactions
Current Pharmaceutical Biotechnology Anti Citrullinated Protein Antibodies and Mechanism of Action of Common Disease Modifying Drugs - Insights in Pathomechanisms of Autoimmunity
Current Pharmaceutical Design Molecular Strategies for the Treatment of Huntingtons Disease
Current Pharmacogenomics Neurobiological Underpinnings of the Estrogen - Mood Relationship
Current Psychiatry Reviews Meet Our Editorial Board Member
Current Neuropharmacology Editorial: Brain Imaging and Automatic Analysis in Neurological and Psychiatric Diseases – Part I
CNS & Neurological Disorders - Drug Targets Metabolomics and the Diagnosis of Human Diseases -A Guide to the Markers and Pathophysiological Pathways Affected
Current Medicinal Chemistry Recent Developments in the Treatment of Alcoholic Chronic Pancreatitis
Current Drug Abuse Reviews Editorial [The Upper Airway Resistance Syndrome: Fact or Fiction?]
Current Respiratory Medicine Reviews The Long and Winding Road to Cancer Treatment: The Trail System
Current Pharmaceutical Design Early Expression of Neuronal Dopaminergic Markers in a Parkinson’s Disease Model in Rats Implanted with Enteric Stem Cells (ENSCs)
CNS & Neurological Disorders - Drug Targets Nerve Growth Factor: Structure, Function and Therapeutic Implications for Alzheimers Disease
Current Drug Targets - CNS & Neurological Disorders Biological Responses to Hydrogen Molecule and its Preventive Effects on Inflammatory Diseases
Current Pharmaceutical Design Linagliptin and Newer DPP-4 Inhibitors: Newer Uses and Newer Indications
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery The Prevalence of Depression in Alzheimer’s Disease: A Systematic Review and Meta-Analysis
Current Alzheimer Research Aripiprazole Addition to Serotonin Reuptake Inhibitor in Treatment-Resistant Obsessive-Compulsive Disorder
Current Psychopharmacology Meet Our Editorial Board Member
Current Alzheimer Research